[Endocrinology 1995-1996].
In a brief review of advances in endocrinology in the last two years the author discusses above all the vain expectations of a drug against obesity-the adipose tissue hormone leptin. Its elevated blood level in human obesity indicates that its secretion depends on the mass of adipose tissue and it is not certain whether leptin reduces the food intake in humans. Perhaps resistance to leptin is involved. New receptor diseases were revealed: mutation of LH receptors leads in both sexes to hypogonadism. Mutation of the calcium receptor in parathyroid cells leads to familial hypocalciuric hypercalcaemia or autosomal dominant hypocalcaemia. The complex regulation of the tonus of the vascular wall by endothelins is still the object of interest. Aquaporin is a renal protein which mediates the action of vasopressin. In the sphere of stress evidence is emerging on the participation of CRH in brain activity and the possibility to influence autoimmune inflammations and perhaps even AIDS by interference with the CRH-proopiomelanocortin-ACTH-cortisol system.
Schreiber
V
V
Laborator pro endokrinologii a metabolismus 1. LF UK a VFN, Praha.
D004700:Endocrine System Diseases / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D020738:Leptin; D009765:Obesity / Q000628:therapy; D011506:Proteins / Q000627:therapeutic use
D020738:Leptin; D011506:Proteins